COPD: Which Treatment Is Right for My Patient CME/CE

Author Information and Disclosures

Release Date: December 29, 2006Reviewed and Renewed: January 10, 2008Valid for credit through January 10, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s) for physicians;
Nurses - 1.0 nursing contact hours (0.25 contact hours are in the area of pharmacology.)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2006 Medscape.


Boehringer Ingelheim Corporation, Pfizer Inc

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify different forms of chronic obstructive pulmonary disease (COPD), including emphysema, chronic obstructive bronchitis, and alpha-1 antitrypsin deficiency.
  2. Discuss severity levels of COPD.
  3. Describe some of the current approaches to selecting therapy for COPD.
Authors and Disclosures

Barry Make, MD
Disclosure: Barry Make, MD, has disclosed that he has received grants for clinical research from GlaxoSmithKline, Boehringer-Ingelheim, and Pfizer. Dr. Make has also disclosed that he has served as an advisor to GlaxoSmithKline, Boehringer-Ingelheim, Pfizer, Dey, AstraZeneca, Altana, and Schering and has given educational talks on behalf of GlaxoSmithKline, Boehringer-Ingelheim, Pfizer, and Schering.


Fernando J. Martinez, MD, MS
Disclosure: Fernando J. Martinez, MD, MS, has disclosed that he has served as an advisor or consultant for Pfizer, Boehringer-Ingelheim, Intermune, GlaxoSmithKline, Aventis, Altana, Dey, and OrthoMcNeil.


Margaret A. Clark, RN, RRT-NPS
Disclosure: Margaret A. Clark, RN, RRT-NPS, has disclosed no relevant financial relationships.


 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Approved for 1.0 contact hour(s) of continuing nursing education for RNs and NPs; 0.25 contact hours are in the area of pharmacology.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.